Patents by Inventor Jian Feng

Jian Feng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200210826
    Abstract: Provided is an intelligent analysis system for inner detecting magnetic flux leakage (MFL) data in pipelines, including a complete data set building module, a discovery module, a quantization module and a solution module, wherein: a complete data set building method is adopted in the complete data set building module to obtain a complete magnetic flux leakage data set; a pipeline connecting component discovery method is adopted in the discovery module to obtain the precise position of a weld; an anomaly candidate region search and identification method is adopted in the discovery model to find out magnetic flux leakage signals with defects; a defect quantization method based on a random forest is adopted in the quantization module to obtain a defect size; and a pipeline solution based on an improved ASME B31G standard is adopted in the solution module to output an evaluation result.
    Type: Application
    Filed: February 13, 2019
    Publication date: July 2, 2020
    Inventors: Jin hai LIU, Ming rui FU, Sen xiang LU, Hua guang ZHANG, Da zhong MA, Gang WANG, Jian FENG, Xin bo ZHANG, Ge YU, Hong qiu WEI
  • Publication number: 20200197562
    Abstract: The present invention is directed to bioresorbable polymers to be used as bone and tissue adhesives. The present invention is also directed to the synthesis of bioresorbable polymeric molecules bearing adhesive moieties and the use of such compounds in methods to glue and stabilize fractured bones and damaged tissues. The present invention is also directed to the use of such compounds as adhesive sealants for applications in wound care. The present invention is also directed to the use of such compounds as biodegradable ink for applications in tissue engineering and 3D printing. The present invention also relates to the use of such compounds as drug delivery platforms.
    Type: Application
    Filed: April 27, 2018
    Publication date: June 25, 2020
    Inventors: Teng Xue, Gianluigi Luppi, Natalia Ruggeri Savietto, Howard K. Bowman III, Paul Joseph Spencer, Andreas Karau, Jian-Feng Zhang, Rosario Lizio, Marshall Scott Jones
  • Patent number: 10683842
    Abstract: The present invention discloses a wind turbine yaw control method and system, the method comprising the following steps: establishing a reference model, giving the optimal yaw reference model different wind speeds for wind shift angles; using model reference adaptive control; getting the adaptive control input so that the difference between the actual yaw angle deviation of the wind and the optimal wind yaw angle deviation is at a minimum. The wind turbine yaw control method and system of the present invention can adaptively track the wind speed in different sections of the optimum wind yaw deviation, improve operating performance under the influence of factors such as wind direction measurement and bias of the yaw system in order to achieve maximum efficiency absorption of wind energy, as well as optimize wind turbine power generation to improve economic efficiency and the operation of the entire wind farm.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: June 16, 2020
    Inventors: Jingchun Chu, Ling Yuan, Xingjian Wu, Jian Feng
  • Publication number: 20200183678
    Abstract: Examples described relate to classifying software. In an example, a determination may be made whether a software installation directory includes a file to run software. In response to a determination that the software installation directory includes a file to run the software, information may be extracted from text data associated with the software installation directory using named entity recognition technique. The files in the software installation directory may be classified as one of a primary file, a secondary file, or a tertiary file based on respective relevance scores of the files, wherein the respective relevance scores may represent respective relevance of the files against the extracted information.
    Type: Application
    Filed: December 8, 2016
    Publication date: June 11, 2020
    Inventors: XIANG TAN, JIN WANG, QlUXIA SONG, JIAN-FENG HAN, YI XU
  • Publication number: 20200166815
    Abstract: The present invention relates to a display device comprising: a display panel having a plurality of pixels and a plurality of source lines, wherein each of the pixels is electrically connected to a respective source line; and an SD IC for providing pixel voltages and receiving a noise storage control signal and a noise output control signal; characterized in that the SD IC further comprises a noise reduce module to store voltage levels of the pixel voltages as compensating voltages based on the noise storage control signal and to output the compensating voltages based on the noise output control signal, wherein during a normal period, the SD IC outputs the pixel voltages to the pixels; during a compensation period, the SD IC outputs the compensating voltages to the pixels; wherein the noise output control signal is phased-delayed with respect to the noise storage control signal.
    Type: Application
    Filed: September 13, 2018
    Publication date: May 28, 2020
    Inventors: Chung-Yu HUANG, Jian-Feng LI, Kai-Yuan SIAO
  • Patent number: 10654922
    Abstract: The present disclosure relates to chimeric molecules which are fusion proteins comprising two components: an Ang-2 binding peptide linked to either a VEGF antibody or a VEGF receptor-Fc fusion protein. The Ang2 peptide, VEGF antibody, and VEGF receptor-Fc fusion proteins are each defined below with reference to percent identity to a reference sequence. The chimeric molecule is a fusion protein, dual antagonist of Ang2 and VEGF for treatment of cancers, proliferative retinopathies, neovascular glaucoma, macular edema, AMD, and rheumatoid arthritis.
    Type: Grant
    Filed: May 11, 2017
    Date of Patent: May 19, 2020
    Assignees: AskGene Pharma Inc., Jiangsu Aosaikang Pharmaceutical Co., Ltd.
    Inventors: Yuefeng Lu, Jian-Feng Lu
  • Publication number: 20200131260
    Abstract: The present disclosure relates to chimeric molecules which are fusion proteins comprising two components: an Ang-2 binding peptide linked to either a VEGF antibody or a VEGF receptor-Fc fusion protein. The Ang2 peptide, VEGF antibody, and VEGF receptor-Fc fusion proteins are each defined below with reference to percent identity to a reference sequence. The chimeric molecule is a fusion protein, dual antagonist of Ang2 and VEGF for treatment of cancers, proliferative retinopathies, neovascular glaucoma, macular edema, AMD, and rheumatoid arthritis.
    Type: Application
    Filed: January 13, 2020
    Publication date: April 30, 2020
    Applicants: AskGene Pharma Inc., Jiangsu Aosaikang Pharmaceutical Co., Ltd.
    Inventors: Yuefeng Lu, Jian-Feng Lu
  • Patent number: 10638406
    Abstract: The present invention relates to methods and apparatuses for providing selective network access, wherein a cell type indication is provided based on at least one of a preamble and a header portion of a broadcast signal. At the receiving end, it is checked based on at least one of the preamble and the header portion, whether broadcast signals are received from different first and second cell types. The first cell type is selected for network access, if both broadcast signals from the first and second cell types are received with sufficient strength.
    Type: Grant
    Filed: June 25, 2015
    Date of Patent: April 28, 2020
    Assignee: HMD Global Oy
    Inventors: Hai Jiang, Jian Feng Kang, Xiaoyi Wang, Chao Wei, Yi Wu, Dong Mei Zhang
  • Publication number: 20200125166
    Abstract: Technologies for performing user-specific calibration of eye tracking systems for Near-Eye-Display (NED) devices. The NED device may sequentially present different virtual stimuli to a user while concurrently capturing instances of eye tracking data. The eye tracking data reveals calibration ellipse centers that uniquely correspond to individual virtual stimuli. The calibration ellipse centers may be used define a polygon grid in association with a sensor plane. The resulting polygon grid is used during operation to interpolate the real-time gaze direction of the user. For example, a real-time instance of eye tracking data may be analyzed to determine which particular polygon of the polygon grid a real-time ellipse center falls within. Then, distances between the real-time ellipse center and the vertices of the particular polygon may be determined. A proportionality factor is then determined based on these distances and is used to interpolate the real-time eye gaze of the user.
    Type: Application
    Filed: May 16, 2019
    Publication date: April 23, 2020
    Inventors: Sergio ORTIZ EGEA, Jian Feng GAO, Alfonsus D. LUNARDHI, Venkata Satya Raghavendra BULUSU
  • Publication number: 20200121183
    Abstract: Techniques for implementing eye tracking using various real-time computational solutions to a three-dimensional eye tracking framework. An exemplary eye tracking system for a NED device includes sensors that are directed toward and angularly offset from a user's eyes in a manner that causes circular features (e.g., irises and/or pupils) of the user's eyes to appear elliptical within sensor planes of the individual sensors. An iris and/or pupil of an eye will appear circular when the eye is looked at straight on (i.e., perpendicular to an optical axis of the eye's lens) but elliptical when observed from an angular offset. The eye tracking systems and methods disclosed herein exploit these principles to track movements of the user's eyes with a higher degree of accuracy than conventional eye tracking systems.
    Type: Application
    Filed: May 16, 2019
    Publication date: April 23, 2020
    Inventors: Sergio ORTIZ EGEA, Jian Feng GAO, Alfonsus D. LUNARDHI, Venkata Satya Raghavendra BULUSU
  • Publication number: 20200116950
    Abstract: An outdoor rated assembly is configured to blind mate opposing fiber optic connectors. An outdoor rated adapter has a first non-outdoor rated fiber optic connector and an outdoor rated connector has a second non-outdoor rated fiber optic connector. The opposing connector and adapter are mated to form an outdoor rated assembly to protect the two internal fiber optic connectors from moisture and debris. The outdoor rated assembly has a safety spring assembly to prevent the outdoor connector components from separating and to support a push/pull attachment and release of the outdoor connector from the outdoor adapter.
    Type: Application
    Filed: October 11, 2019
    Publication date: April 16, 2020
    Inventors: Yim WONG, Kenji IIZUMI, Jin Jian FENG
  • Publication number: 20200116945
    Abstract: A fiber optic connector is spliced to an optical fiber provided by a sheathed optical fiber and an optical fiber pigtail. The connector houses a protective sleeve that secures the splice area from damage due to movement of optical fibers during connecter use. The protective sleeve retains the sheathed optical fiber at a first end and secures the protective sleeve to a distal end of a ferrule flange assembly at a second end.
    Type: Application
    Filed: October 10, 2019
    Publication date: April 16, 2020
    Inventors: Yim WONG, Jin Jian FENG
  • Publication number: 20200102381
    Abstract: The present disclosure relates to fusion molecules and chimeric molecules which comprise two components: an Ang-2 antagonist peptide linked to a VEGF-binding moiety. Further disclosed are methods of using said chimeric molecules to treat a patient cancer, proliferative retinopathy, neovascular glaucoma, macular edema, wet age-related macular degeneration (wAMD), macular edema following retinal vein occlusion (RVO), diabetic macular edema (DME), or diabetic retinopathy (DR).
    Type: Application
    Filed: April 10, 2019
    Publication date: April 2, 2020
    Applicant: AskGene Pharma Inc.
    Inventors: Yuefeng Lu, Jian-Feng Lu
  • Patent number: 10592295
    Abstract: An injection system and method for monitoring and controlling task execution in a distributed computer system. The distributed computing environment is comprised of a plurality of computing nodes for executing an application, wherein the application is divided into tasks that are executed within containers on each of the nodes, and the tasks process vectors comprised of one or more data elements. A control plug-in injected into a specified container for execution with the tasks, wherein the control plug-in profiles footprint information for a targeted vector operated on by the tasks executed within the specified container.
    Type: Grant
    Filed: February 28, 2017
    Date of Patent: March 17, 2020
    Assignee: International Business Machines Corporation
    Inventors: Peng Hui Jiang, Rongsong Shen, Hang Xiao, Jian Feng Zhang
  • Patent number: 10570490
    Abstract: A method of strengthening a dilute magnesium alloy sheet includes providing a dilute magnesium alloy sheet, which includes a magnesium alloy consisting essentially of (wt %): >0 to 3.0 of Zn; >0 to 1.5 of Ca; 0 to 1.0 of Zr; 0 to 1.3 of a rare earth element or mixture of the same; 0 to 0.3 of Sr; 0 to 0.7 of Al, the balance of Mg and other unavoidable impurities, wherein the total weight % of alloying elements is less than 3%; subjecting the dilute magnesium alloy sheet to plastic deformation, in which the tensile plastic strain should exceed 0.5%, but be less than 8% to form a pre-deformed magnesium alloy sheets; and subjecting the pre-deformed magnesium alloy sheets to an ageing treatment in a temperature range of 80 to 250° C. for at least 1 minute, thereby forming a strengthened magnesium alloy sheet.
    Type: Grant
    Filed: April 8, 2015
    Date of Patent: February 25, 2020
    Assignee: Baoshan Iron & Steel Co., Ltd.
    Inventors: Jian-Feng Nie, Zhuoran Zeng, Mingzhe Bian, Christopher Huw John Davies, Nick Birbilis, Shiwei Xu, Pijun Zhang
  • Publication number: 20200056150
    Abstract: Provided herein are compositions and methods for generation of naive human pluripotent stem cells. The method comprises incubation of iPSCs under 5% O2 in a medium comprising 5% glucose, an MEK inhibitor, a GSK3? inhibitor, human leukemia inhibitory factor (LIF), human insulin and Torin 1. The method does not need any other inhibitors or transgene expression. The naive human pluripotent cells can be used to generate a large amount of mature human cells from all three germ layers in host non-human animals.
    Type: Application
    Filed: November 1, 2017
    Publication date: February 20, 2020
    Inventor: Jian FENG
  • Publication number: 20200040101
    Abstract: Described and provided herein are novel antibodies for Claudin 18.2. Also described and provided are pharmaceutical compositions of the antibodies and methods of use for the treatment of cancer.
    Type: Application
    Filed: July 18, 2019
    Publication date: February 6, 2020
    Applicants: AskGene Pharma Inc., Jiangsu AoSaiKang Pharmaceutical Co., Ltd.
    Inventors: Yuefeng Lu, Kurt Shanebeck, Lu Li, Lei Liu, Shiwen Zhang, Lan Yang, Jian-Feng Lu
  • Patent number: 10555242
    Abstract: The present invention relates to methods and apparatuses for providing selective network access, wherein a cell type indication is provided based on at least one of a preamble and a header portion of a broadcast signal. At the receiving end, it is checked based on at least one of the preamble and the header portion, whether broadcast signals are received from different first and second cell types. The first cell type is selected for network access, if both broadcast signals from the first and second cell types are received with sufficient strength.
    Type: Grant
    Filed: June 6, 2008
    Date of Patent: February 4, 2020
    Assignee: HMD Global Oy
    Inventors: Hai Jiang, Jian Feng Kang, Xiao Yi Wang, Chao Wei, Yi Wu, Dong Mei Zhang
  • Publication number: 20200032094
    Abstract: Provided herein is an aqueous polymer dispersion including A) a polymer synthesized from monomers including a) 1.0 to 90% by weight of at least one alkyl (meth)acrylate; b) 0.1 to 10% by weight of at least one ethylenically unsaturated acid or vinyl monomer with latent ionic groups; c) 0 to 5.0% by weight of at least one monoethylenically unsaturated monomer having at least one keto or aldehyde group; d) 1.0 to 90% by weight of at least one vinyl ester of saturated aliphatic monocarboxylic acid in which the carboxyl groups are attached to tertiary and/or quaternary carbon atoms; e) 0 to 20% by weight of at least one vinyl aromatics; and f) 0 to 20% by weight, based on the total amount of monomers for the synthesis of polymer A), of at least one hydroxyalkyl (meth)acrylate. Also included herein is an ink anchorage primer that enhances ink bonding.
    Type: Application
    Filed: September 14, 2017
    Publication date: January 30, 2020
    Inventors: Li Li, Jian Feng Xia
  • Patent number: 10495635
    Abstract: A testing device for testing the analytes in liquid samples, including: a test chamber (115) used to accommodate testing components (102); an injection port (120); a device for gas exchange (113) between inside and out side of the testing chamber (115). The gas pressure difference makes the liquid sample enter the testing chamber (115) automatically to complete the testing of analytes in liquid samples.
    Type: Grant
    Filed: October 5, 2014
    Date of Patent: December 3, 2019
    Assignee: Abon Biopharm (Hangzhou) Co., Ltd.
    Inventor: Wang Jian-Feng